Table 3 Characteristics of extraocular lesions detected in seven patients
Patient No. | Location of OAMLa | Stage | Locations of extraocular MALTb lymphoma | SUVmax of OAML | SUVmax of extraocular lesions | |
|---|---|---|---|---|---|---|
Before PET | After PET | |||||
1 | Lacrimal gland | IE | IVE | Left kidneyc | 2.7 | 7.4 |
Lung | 1.5 | |||||
Retroperitoneal lymph nodes | 5.5 | |||||
15 | Lacrimal gland | IVE | IVE | Bilateral palatine tonsilsc | R 2.4; L 3.0 | 8.0 |
Bone marrow | NAd | |||||
22 | Lacrimal gland | IE | IIE | Bilateral cervical nodes | R 4.2; L 2.7 | 4.9 |
35 | Lacrimal gland | IE | IIE | Right parotid gland | 2.1 | 3.7 |
Left submandibular gland | 3.6 | |||||
40 | Orbit | IE | IIE | Right cervical level I nodec | 10.5 | 10.8 |
47 | Orbit | IE | IVE | Sacral foramen | 11.0 | 6.7 |
Right parotid gland | 3.6 | |||||
49 | Orbit | IE | IIE | Bilateral cervical nodes | R 4.9; L 6.5 | 5.5 |